The Hidden Cost of Building the Wrong Kind of Healthcare Company

Hatched by Ben H.

Apr 26, 2026

11 min read

5 views

73%

When a company sells its future to pay for its present

What if the biggest threat to a healthcare company is not that it grows too slowly, but that it grows around the wrong problems?

That is the uncomfortable lesson hiding inside two very different business events: a retail giant trying to unload a healthcare asset it once treated as strategic, and millions of Medicaid patients losing coverage because a state system cannot reliably reach them. On the surface, one story is about capital allocation and the other is about public administration. In reality, both are about the same failure mode: mistaking motion for mission.

A company can buy its way into a new identity, just as a health system can create the appearance of eligibility management, outreach, and continuity of coverage. But if the underlying machinery is brittle, the effort becomes expensive theater. The result is a paradox that shows up in both corporate strategy and public policy: the more an organization tries to look like it is solving a structural problem, the more clearly its weakest assumptions are exposed.

Walgreens is now considering selling an asset that once symbolized its transformation into a more integrated healthcare company. Meanwhile, Medicaid redeterminations are showing that large numbers of people do not lose coverage because they are ineligible, but because the system fails at something much more basic, keeping track of them. Those two facts belong in the same conversation because both ask the same deeper question: What is the real engine of healthcare value, and what happens when leaders invest in everything except the engine?

The illusion of strategic transformation

Healthcare is full of companies that want to become something more elevated than what they started as. A retailer wants to become a care platform. A payer wants to become a health navigator. A provider wants to become a consumer brand. The language changes quickly. The operating reality changes slowly, if at all.

That gap matters because transformation is often mistaken for acquisition. Buying a specialty service, a primary care group, or an adjacent business can look like a move into the future. But acquisitions do not automatically create a new capability. Sometimes they simply add a new layer of complexity on top of the old business. If the core organization does not know how to integrate the asset, measure its value, and connect it to a broader system, the asset becomes an expensive proof point rather than a durable advantage.

That is what makes a potential sale of a specialized healthcare unit so revealing. The question is no longer whether the asset was strategically interesting in theory. The question is whether it actually changed the economics, behavior, and identity of the parent company. If it did not, then the problem was never the size of the bet. It was the quality of the integration.

This is not unique to corporations. Public systems do the same thing. They announce eligibility reviews, outreach campaigns, digital portals, and process improvements. But if the underlying contact data is stale, the forms are confusing, and the follow-up loop is broken, then the system has not become more capable. It has only become more ceremonial.

The core failure is not absence of ambition. It is the substitution of visible activity for invisible capability.

That sentence applies equally to a company trying to reinvent itself and to a state trying to manage access to health coverage. In both cases, the hardest work is not announcing change. It is building the boring infrastructure that makes change real.

Healthcare is not a logo, it is a logistics problem

One reason these stories connect so well is that they strip away a common illusion about healthcare. People often talk about it as if it were mostly a matter of brands, care settings, or reimbursement models. In practice, healthcare is just as much a logistics system as it is a clinical one. It depends on addressing, routing, reminders, handoffs, eligibility checks, and timing.

Think of it like a delivery network. A beautiful warehouse does not matter if the packages never get to the right house. A well-funded clinic does not matter if patients cannot be found, enrolled, scheduled, or retained. A sophisticated healthcare brand does not matter if the organization cannot execute the simple, repetitive tasks that make the brand meaningful.

That is why administrative redeterminations are so revealing. When a large share of Medicaid losses happens because people cannot be reached or paperwork is not completed, the issue is not merely bureaucratic inconvenience. It is a sign that access to care is being determined by operational friction. The system is not deciding based on need, but based on whether the machinery can successfully complete a transaction.

Now apply that same logic to a healthcare company that has purchased an asset to deepen its role in care delivery. If the asset does not improve coordination, patient retention, or cost management in a measurable way, then it is not a healthcare capability. It is a financing event pretending to be a strategic one.

This is why some healthcare investments look better in investor presentations than they do in real life. They promise to connect the dots between retail, primary care, specialty services, and home care. But the real question is not whether the dots can be connected conceptually. It is whether the organization has the operational architecture to connect them repeatedly, at scale, under pressure.

The most durable healthcare companies do not simply own more pieces of the journey. They own the glue: the data, workflows, outreach systems, and incentives that keep the journey from breaking apart.

The hidden metric is continuity

If there is one metric connecting both stories, it is continuity.

For Medicaid, continuity means a person stays covered when they are still eligible. It means the system can find them, verify them, and keep the relationship intact. For a healthcare company, continuity means a strategic acquisition becomes part of the operating model, not an isolated annex. It means the patient experience, financial performance, and care outcomes improve because the organization can keep people connected over time.

Continuity is easy to underestimate because it is not glamorous. New facilities get headlines. New digital products get demos. New acquisitions get valuation multiples. But continuity is where value compounds. Without it, every gain leaks away through churn, missed communication, and fragmented responsibility.

This is why so many healthcare strategies fail in a way that feels strangely similar to administrative disenrollment. The surface explanation is always different, but the deeper pattern is the same: the organization cannot hold onto people long enough for its strategy to matter.

A retailer entering healthcare may believe the prize is scale. A state program may believe the prize is compliance. In both cases, the real prize is retention with reliability. Can you keep the person in the system, keep the record accurate, keep the handoff intact, and keep the relationship alive?

If not, then scale becomes noise. You can have millions of members, patients, visits, or prescriptions, and still fail in the one dimension that matters most: whether the organization remains connected to the person across time.

Healthcare value is often not created by the first transaction. It is created by preventing the second one from breaking.

That is a far less intuitive way to think about strategy, but it is more accurate. The second interaction, the follow-up, the renewal, the re-contact, the redetermination, these are where systems prove whether they are robust or merely ambitious.

A framework for seeing the difference between assets and capabilities

One useful way to interpret these examples is to separate assets from capabilities.

An asset is something you can buy, sell, or point to in a presentation. A capability is something your organization can do reliably, repeatedly, and better than others. Many firms confuse the two because assets are tangible and capabilities are often invisible until they fail.

A specialty pharmacy operation, a retail clinic, a primary care network, or an eligibility portal can all be valuable assets. But none of them becomes strategically meaningful unless it strengthens a capability such as:

Patient identification: knowing who needs help and where they are.
Communication: reaching the person with the right message at the right time.
Coordination: transferring responsibility without losing the thread.
Retention: keeping the person engaged long enough to produce outcomes.
Measurement: understanding whether the system actually improved anything.

This framework helps explain why some acquisitions disappoint even when they are operationally active. The business may add volume, but not capability. It may add complexity, but not resilience. It may improve its appearance as a healthcare company, but not its underlying performance as one.

The same framework also explains why administrative systems produce losses that feel avoidable. The state may have the policy, the funding, and the intent, but if it lacks the capability to identify, contact, and process members cleanly, then coverage becomes brittle. The result is not just a paperwork issue. It is a capability failure masquerading as policy execution.

The most useful question for leaders is therefore not, “What did we buy?” or “What process did we announce?” It is, “What do we now do better, more consistently, because of this?” If the answer is unclear, the strategy is probably decorative.

What this means for healthcare leaders and investors

There is a temptation to read stories like these as proof that healthcare transformation is overhyped. That would be too cynical. The better conclusion is more demanding: transformation is real only when it is operationally legible.

For investors, that means paying less attention to the story of becoming a healthcare company and more attention to the mechanics of becoming one. Ask whether the organization can reduce friction, improve retention, and make care easier to navigate. Ask whether the asset changes the cost of coordination. Ask whether the company is gaining a capability that competitors cannot easily copy.

For operators, it means resisting the seduction of visible growth. A new business line is not necessarily a new strength. If it requires constant subsidies, creates integration drag, or sits awkwardly beside the core business, it may be draining attention from the capabilities that really matter.

For policymakers, the lesson is even sharper. Eligibility systems are not merely administrative back offices. They are part of the care infrastructure. If the state cannot keep people connected to coverage, it is not just failing at paperwork. It is interrupting care before care can even begin.

There is also a broader strategic lesson here about scale. At a certain point, scale stops being an answer and becomes a test. Large organizations do not fail because they are small and underpowered. They fail because their systems become too complicated for their own promises. Complexity multiplies every weak assumption. The more interdependent the structure, the more punishing the administrative error.

That is why a seemingly mundane issue such as outdated contact information can carry enormous consequences. It is not mundane at all. It is the point where the abstraction of policy collides with the reality of human attention, mobility, and confusion. The same is true of corporate integration. The deal may look sophisticated, but if the handoffs are clumsy, the strategic thesis collapses into a balance sheet problem.

Key Takeaways

Ask what capability is being created, not just what asset is being acquired. A good healthcare strategy improves coordination, retention, and measurement, not just footprint.
Treat administration as core infrastructure. Contact data, outreach, eligibility checks, and follow-up processes are not side tasks. They determine whether the system works.
Look for continuity, not just growth. The real test of healthcare value is whether people stay connected across time, not whether they appear once in a dashboard.
Beware of transformation theater. If an organization cannot explain how a new initiative changes day to day execution, it is probably adding complexity rather than strength.
Measure leakage. Whether in a company or a public program, watch where people fall out of the system. Leakage is often the best indicator of strategic weakness.

The deepest lesson: healthcare is won in the gaps

The most important thing these stories reveal is that healthcare is not primarily decided by big moments. It is decided in the gaps between moments: between enrollment and renewal, between acquisition and integration, between intent and follow through.

That is why the flashiest moves are often the least decisive. A company can buy an asset that appears to signal its future, yet still fail to build the machinery that makes the future work. A state can launch a redetermination process, yet still lose eligible people because it cannot maintain contact. In both cases, the real contest is not over strategy on paper. It is over whether the organization can preserve continuity in a system that is naturally prone to fragmentation.

So perhaps the best way to judge healthcare transformation is not by asking what got added, but by asking what stayed connected. What relationships endured? What handoffs were seamless? What data remained current? What people remained visible to the system?

In healthcare, the highest form of value is not expansion. It is the ability to remain responsible for someone after the headline fades.

That reframes the entire conversation. The question is not whether a company or government program can look bigger, broader, or more sophisticated. The question is whether it can become harder to lose. That is the real measure of a healthcare system, and the real test of any organization that claims to be building one.